Insider · CIK 0001834411

Booth Andrew

Reports to the SEC for 1 company · VANCOUVER

sec.gov

Transactions

Companies

Filings

CIK

0001834411

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-14	ABCLAbCellera Biologics Inc.P Purchase	Chief Financial Officer	PPurchase	+37.2K sh	$10.32	+$384K	482,800
2026-06-03	ABCLAbCellera Biologics Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+250K sh	$0.19	+$47.5K	445,600
2026-06-03	ABCLAbCellera Biologics Inc. · Share option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−250K sh	—	—	8,501,849
2026-02-27	ABCLAbCellera Biologics Inc.P Purchase	Chief Financial Officer	PPurchase	+42.6K sh	$3.42	+$146K	195,600
2026-01-01	ABCLAbCellera Biologics Inc. · Share option (right to buy)A Award	Chief Financial Officer	AAward	+809K sh	—	—	8,751,849
2025-01-01	ABCLAbCellera Biologics Inc. · Share option (right to buy)A Award	Chief Financial Officer	AAward	+1.35M sh	—	—	7,942,951
2024-01-14	ABCLAbCellera Biologics Inc. · Share option (right to buy)A Award	Chief Financial Officer	AAward	+770K sh	—	—	6,590,897
2023-05-26	ABCLAbCellera Biologics Inc.P Purchase	Chief Financial Officer	PPurchase	+14.5K sh	$6.85	+$99.3K	153,000
2022-12-20	ABCLAbCellera Biologics Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+50K sh	$0.19	+$9,500	188,500
2022-12-20	ABCLAbCellera Biologics Inc.G Gift	Chief Financial Officer	GGift	−50K sh	—	—	138,500
2022-12-20	ABCLAbCellera Biologics Inc. · Share option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−50K sh	—	—	5,820,481
2022-12-01	ABCLAbCellera Biologics Inc. · Share Options (right to buy)A Award	Chief Financial Officer	AAward	+486K sh	—	—	5,870,481
2022-05-12	ABCLAbCellera Biologics Inc.P Purchase	Chief Financial Officer	PPurchase	+85K sh	$5.79	+$492K	138,500
2021-12-10	ABCLAbCellera Biologics Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+500K sh	$0.32	+$160K	553,500
2021-12-10	ABCLAbCellera Biologics Inc. · Share Options (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−500K sh	—	—	5,384,820
2021-12-10	ABCLAbCellera Biologics Inc.G Gift	Chief Financial Officer	GGift	−500K sh	—	—	53,500
2021-12-07	ABCLAbCellera Biologics Inc. · Share Option (right to buy)A Award	Chief Financial Officer	AAward	+406K sh	—	—	5,884,820
2021-11-11	ABCLAbCellera Biologics Inc.P Purchase	Chief Financial Officer	PPurchase	+53.5K sh	$14.74	+$789K	53,500
2021-11-11	ABCLAbCellera Biologics Inc.P Purchase	Chief Financial Officer	PPurchase	+14K sh	$14.61	+$205K	130,959
2021-06-09	ABCLAbCellera Biologics Inc.S Sale	Chief Financial Officer	SSale	−1.2M sh	$25.50	−$30.6M	0
2021-06-07	ABCLAbCellera Biologics Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+600K sh	$0.19	+$114K	600,000
2021-06-07	ABCLAbCellera Biologics Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+600K sh	$0.32	+$192K	1,200,000
2021-06-07	ABCLAbCellera Biologics Inc. · Share Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−600K sh	—	—	300,000
2021-06-07	ABCLAbCellera Biologics Inc. · Share Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−600K sh	—	—	4,950,000

Recent filings

Accepted (ET)
Aug 144
Booth Andrew0001834411-26-000008
SEC(opens sec.gov)
Jun 34
Booth Andrew0001834411-26-000006
SEC(opens sec.gov)
Feb 274
Booth Andrew0001834411-26-000004
SEC(opens sec.gov)
Jan 54
Booth Andrew0001834411-26-000002
SEC(opens sec.gov)
Jan 34
Booth Andrew0001628280-25-000233
SEC(opens sec.gov)
Jan 164
Booth Andrew0001703057-24-000004
SEC(opens sec.gov)
May 264
Booth Andrew0001209191-23-032484
SEC(opens sec.gov)
Dec 224
Booth Andrew0001209191-22-062412
SEC(opens sec.gov)
Dec 54
Booth Andrew0001209191-22-059568
SEC(opens sec.gov)
May 164
Booth Andrew0001209191-22-029091
SEC(opens sec.gov)
Feb 35
Booth Andrew0001209191-22-006960
SEC(opens sec.gov)
Dec 104
Booth Andrew0001209191-21-069084
SEC(opens sec.gov)
Dec 94
Booth Andrew0001209191-21-068849
SEC(opens sec.gov)
Nov 154
Booth Andrew0001209191-21-064378
SEC(opens sec.gov)
Jun 104
Booth Andrew0000899243-21-022988
SEC(opens sec.gov)

Companies

AbCellera Biologics Inc.Chief Financial OfficerABCL

Address

C/O ABCELLERA BIOLOGICS INC 150 W 4TH AVENUE

VANCOUVER